CTNM
Contineum Therapeutics Inc. - Ordinary Shares - Class A

138
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 06,
After Hours

Estimated EPS

-$0.46

Estimated Rev

$7.5M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.46
--
--
N/A
Q2 '25
-$0.44
-$0.62
-40.79%
MISSED
Q1 '25
-$0.56
-$0.62
-9.73%
MISSED
Q4 '24
-$0.42
-$0.56
-32.28%
MISSED
Q3 '24
-$0.41
-$0.40
2.44%
BEAT

Latest CTNM News

View

Advertisement. Remove ads.

Advertisement. Remove ads.